Income Statement Align Technology, Inc.

Stocks

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 20:21:51 16/07/2026 BST			5-day change	1st Jan Change
177.68 ^USD	-1.98%		-0.29%	+13.77%

07-14	Cheniere appoints former McKesson CFO to board	RE
07-09	Align Technology, Inc. Announces Resignation of Julie Coletti from Executive Vice President, Chief Legal and Regulatory Officer, Effective August 1, 2026	CI

4865938a21b6ecb29cddf1f961e.Wp8wPpM_cYZFSqGj-752UDfsMiapu4qLxm9zgv1_xHU.Pv1bXfdwQ940etnhycoTfUagbXmc987bjBwft8xOgRAxr3Jr_FNA2RMN7A

Published financial data: ALIGN TECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.95B	3.73B	3.86B	4B	4.03B
Total Revenues	3.95B	3.73B	3.86B	4B	4.03B
Cost of Goods Sold, Total	1.02B	1.1B	1.15B	1.2B	1.22B
Gross Profit	2.94B	2.64B	2.71B	2.8B	2.82B
Selling General & Admin Expenses, Total	1.71B	1.67B	1.7B	1.76B	1.76B
R&D Expenses	250M	305M	347M	364M	370M
Other Operating Expenses	-	53K	-	-	-
Other Operating Expenses, Total	1.96B	1.98B	2.05B	2.13B	2.13B
Operating Income	976M	657M	657M	676M	693M
Interest And Investment Income	3.1M	5.37M	17.26M	20.22M	16.04M
Net Interest Expenses	3.1M	5.37M	17.26M	20.22M	16.04M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-13.3M	-43.8M	-7M	-21M	11.3M
Other Non Operating Income (Expenses)	2.82M	-5.1M	-7.4M	-7.87M	-5.89M
EBT, Excl. Unusual Items	969M	613M	660M	667M	714M
Restructuring Charges	-	-10.2M	-14.02M	-36.97M	-42.93M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-4.99M	9.98M	18.07M
Asset Writedown	-	-1.8M	-	-	-100M
Legal Settlements	43.4M	-	-	-30.97M	-4.18M
Other Unusual Items	-	-2.3M	-	-	-
EBT, Incl. Unusual Items	1.01B	599M	641M	609M	585M
Income Tax Expense	240M	237M	196M	188M	175M
Earnings From Continuing Operations	772M	362M	445M	421M	410M
Net Income to Company	772M	362M	445M	421M	410M
Net Income - (IS)	772M	362M	445M	421M	410M
Net Income to Common Incl Extra Items	772M	362M	445M	421M	410M
Net Income to Common Excl. Extra Items	772M	362M	445M	421M	410M
Per Share Items
Net EPS - Basic	9.78	4.62	5.82	5.63	5.66
Basic EPS - Continuing Operations	9.78	4.62	5.82	5.63	5.66
Basic Weighted Average Shares Outstanding	78.92M	78.19M	76.43M	74.88M	72.54M
Net EPS - Diluted	9.69	4.61	5.81	5.62	5.65
Diluted EPS - Continuing Operations	9.69	4.61	5.81	5.62	5.65
Diluted Weighted Average Shares Outstanding	79.67M	78.42M	76.57M	74.99M	72.59M
Normalized Basic EPS	7.67	4.9	5.4	5.57	6.16
Normalized Diluted EPS	7.6	4.89	5.39	5.56	6.15
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.09B	783M	800M	821M	853M
EBITA	993M	673M	674M	694M	712M
EBIT	976M	657M	657M	676M	693M
EBITDAR	1.13B	843M	860M	867M	901M
Effective Tax Rate - (Ratio)	23.75	39.64	30.59	30.81	29.89
Current Domestic Taxes	186M	223M	163M	109M	66.94M
Current Foreign Taxes	42.68M	56.54M	51.31M	56.65M	74.69M
Total Current Taxes	228M	279M	214M	165M	142M
Deferred Domestic Taxes	-31.46M	-67.84M	-19.96M	4.96M	28.15M
Deferred Foreign Taxes	43.43M	26.12M	1.94M	17.25M	5.16M
Total Deferred Taxes	11.97M	-41.72M	-18.02M	22.22M	33.31M
Normalized Net Income	606M	383M	413M	417M	447M
Supplemental Operating Expense Items
Advertising Expense	326M	-	201M	185M	189M
Selling and Marketing Expenses	326M	-	201M	185M	189M
Research And Development Expense From Footnotes	250M	305M	347M	364M	370M
Net Rental Expense, Total	44.38M	60M	60.63M	45.93M	47.46M
Stock-Based Comp., COGS (Total)	5.63M	6.44M	7.46M	7M	6.18M
Stock-Based Comp., R&D Exp. (Total)	18.04M	23.8M	30.57M	42.73M	47.33M
Stock-Based Comp., SG&A Exp. (Total)	90.66M	103M	116M	124M	132M
Total Stock-Based Compensation	114M	133M	154M	174M	186M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.1B	942M	937M	1.04B	1.09B
Short Term Investments	71.97M	57.53M	35.3M	-	-
Total Cash And Short Term Investments	1.17B	1B	973M	1.04B	1.09B
Accounts Receivable, Total	897M	860M	903M	996M	1.1B
Other Receivables	-	140M	144M	34.03M	55.82M
Notes Receivable	-	-	-	-	-
Total Receivables	897M	1B	1.05B	1.03B	1.16B
Inventory	230M	339M	297M	254M	226M
Prepaid Expenses	70.22M	69.12M	52.49M	82.98M	62.48M
Other Current Assets, Total	125M	16.76M	77.34M	81.58M	75.26M
Total Current Assets	2.49B	2.42B	2.45B	2.49B	2.62B
Gross Property Plant And Equipment	1.56B	1.8B	1.96B	2.05B	2.01B
Accumulated Depreciation	-359M	-450M	-551M	-662M	-767M
Net Property Plant And Equipment	1.2B	1.35B	1.41B	1.38B	1.24B
Long-term Investments	134M	41.98M	8.02M	-	-
Goodwill	419M	408M	420M	443M	492M
Other Intangibles, Total	110M	95.72M	82.12M	103M	93.93M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.53B	1.57B	1.59B	1.56B	1.51B
Deferred Charges Long-Term	31.1M	27.4M	25.1M	25.8M	29.2M
Other Long-Term Assets, Total	17.79M	28.43M	104M	208M	249M
Total Assets	5.94B	5.95B	6.08B	6.21B	6.23B
Liabilities
Accounts Payable, Total	164M	128M	113M	109M	121M
Accrued Expenses, Total	488M	316M	434M	474M	426M
Current Portion of Leases	22.72M	26.57M	29.65M	31.06M	31.94M
Current Income Taxes Payable	33.84M	74.32M	38.1M	48.81M	44.05M
Unearned Revenue Current, Total	1.15B	1.34B	1.43B	1.33B	1.26B
Other Current Liabilities	62.73M	37.8M	23.62M	44.67M	34.88M
Total Current Liabilities	1.92B	1.93B	2.07B	2.04B	1.92B
Long-Term Leases	103M	100M	96.97M	88.21M	82.51M
Unearned Revenue Non Current	137M	161M	138M	102M	85.54M
Other Non Current Liabilities	156M	160M	152M	134M	96.48M
Total Liabilities	2.32B	2.35B	2.45B	2.36B	2.18B
Common Stock, Total	8K	8K	7K	7K	7K
Additional Paid In Capital	999M	1.04B	1.16B	1.36B	1.51B
Retained Earnings	2.62B	2.57B	2.45B	2.48B	2.46B
Comprehensive Income and Other	4.33M	-10.28M	21.17M	5.98M	75.39M
Total Common Equity	3.62B	3.6B	3.63B	3.85B	4.05B
Total Equity	3.62B	3.6B	3.63B	3.85B	4.05B
Total Liabilities And Equity	5.94B	5.95B	6.08B	6.21B	6.23B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	78.8M	76.61M	75.1M	73.6M	71.28M
ECS Total Common Shares Outstanding	78.71M	77.27M	75.08M	73.85M	71.36M
Book Value / Share	46.03	46.61	48.36	52.16	56.74
Tangible Book Value	3.09B	3.1B	3.13B	3.31B	3.46B
Tangible Book Value Per Share	39.31	40.1	41.68	44.77	48.53
Total Debt	125M	127M	127M	119M	114M
Net Debt	-1.17B	-915M	-854M	-925M	-980M
Debt Equivalent Oper. Leases	355M	480M	485M	367M	380M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	123M	173M	145M	124M	107M
Inventories - Work In Process, Total	51.71M	96.56M	91.26M	73.66M	65.68M
Inventories - Finished Goods, Total	55.29M	69.44M	60.15M	56.25M	53.37M
Land - (BS)	58.87M	58.88M	63.88M	63.88M	57.87M
Buildings, Total	310M	466M	518M	530M	525M
Machinery, Total	525M	687M	827M	1.01B	1B
Full Time Employees	22.54K	23.16K	21.61K	20.94K	20.29K
Accumulated Allowance for Doubtful Accounts (Supple)	9.24M	10.34M	14.89M	19.13M	34.21M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	772M	362M	445M	421M	410M
Depreciation & Amortization - CF	92.13M	110M	126M	126M	142M
Amortization of Goodwill and Intangible Assets - (CF)	16.6M	16M	16.4M	18.9M	18.8M
Depreciation & Amortization, Total	109M	126M	142M	145M	160M
(Gain) Loss From Sale Of Asset	-	-	-	-	23.14M
(Gain) Loss on Sale of Investments - (CF)	-	-	4.99M	-5.88M	-18.07M
Asset Writedown & Restructuring Costs	-	-	-	-	77M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	114M	133M	154M	174M	186M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	2.81M	-	-	-	-
Other Operating Activities, Total	20.41M	32.31M	47.2M	76.45M	111M
Change In Accounts Receivable	-262M	21.55M	-105M	-153M	-140M
Change In Inventories	-112M	-130M	30.17M	25.05M	808K
Change In Accounts Payable	19.75M	-36.52M	-7.7M	-843K	5.33M
Change in Unearned Revenues	463M	242M	86.71M	-80.11M	-112M
Change In Income Taxes	12.45M	6.33M	-7.77M	-20.28M	-28.26M
Change in Other Net Operating Assets	33.92M	-187M	-4.69M	157M	-82.22M
Cash from Operations	1.17B	569M	786M	738M	593M
Capital Expenditure	-401M	-292M	-178M	-116M	-102M
Cash Acquisitions	-8M	-12.3M	-	-77.08M	-
Investment in Marketable and Equity Securities, Total	-197M	93.1M	-18.5M	-62.49M	-10M
Other Investing Activities, Total	42.99M	-2.21M	278K	235K	-
Cash from Investing	-563M	-213M	-196M	-255M	-112M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	25.62M	26.15M	26.6M	25.28M	21.75M
Repurchase of Common Stock	-484M	-488M	-615M	-381M	-486M
Other Financing Activities, Total	-	-40M	-10M	-	-
Cash from Financing	-458M	-502M	-598M	-356M	-465M
Foreign Exchange Rate Adjustments	-12.12M	-11.51M	4.67M	-21.15M	35.02M
Net Change in Cash	139M	-158M	-3.84M	106M	51.22M
Supplemental Items
Cash Income Tax Paid (Refund)	203M	232M	295M	177M	135M
Levered Free Cash Flow	596M	274M	618M	621M	485M
Unlevered Free Cash Flow	596M	274M	618M	621M	485M
Change In Net Working Capital	-163M	104M	-88.58M	4.67M	192M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.33	6.91	6.83	6.87	6.96
Return on Total Capital	17.27	10.98	10.98	10.93	10.65
Return On Equity %	22.52	10.01	12.31	11.26	10.39
Return on Common Equity	22.52	10.01	12.31	11.26	10.39
Margin Analysis
Gross Profit Margin %	74.26	70.6	70.1	70.09	69.86
SG&A Margin	43.23	44.84	44.1	44.09	43.51
EBITDA Margin %	27.45	20.96	20.71	20.52	21.15
EBITA Margin %	25.12	18.02	17.44	17.37	17.64
EBIT Margin %	24.7	17.59	17.02	16.89	17.17
Income From Continuing Operations Margin %	19.53	9.68	11.52	10.54	10.17
Net Income Margin %	19.53	9.68	11.52	10.54	10.17
Net Avail. For Common Margin %	19.53	9.68	11.52	10.54	10.17
Normalized Net Income Margin	15.32	10.26	10.68	10.42	11.07
Levered Free Cash Flow Margin	15.07	7.33	16	15.52	12.02
Unlevered Free Cash Flow Margin	15.07	7.33	16	15.52	12.02
Asset Turnover
Asset Turnover	0.73	0.63	0.64	0.65	0.65
Fixed Assets Turnover	3.91	2.92	2.8	2.86	3.08
Receivables Turnover (Average Receivables)	5.08	4.25	4.38	4.21	3.85
Inventory Turnover (Average Inventory)	5.51	3.86	3.63	4.34	5.06
Short Term Liquidity
Current Ratio	1.3	1.26	1.18	1.22	1.36
Quick Ratio	1.08	1.04	0.98	1.02	1.17
Operating Cash Flow to Current Liabilities	0.61	0.3	0.38	0.36	0.31
Days Sales Outstanding (Average Receivables)	71.79	85.85	83.31	86.91	94.87
Days Outstanding Inventory (Average Inventory)	66.29	94.57	100.47	84.33	72.12
Average Days Payable Outstanding	50.39	44.13	39.52	35.19	35.34
Cash Conversion Cycle (Average Days)	87.68	136.3	144.25	136.05	131.64
Long Term Solvency
Total Debt/Equity	3.46	3.52	3.49	3.1	2.83
Total Debt / Total Capital	3.34	3.4	3.37	3	2.75
LT Debt/Equity	2.83	2.79	2.67	2.29	2.04
Long-Term Debt / Total Capital	2.74	2.69	2.58	2.22	1.98
Total Liabilities / Total Assets	39.03	39.45	40.33	38.02	35.04
Total Debt / EBITDA	0.11	0.15	0.15	0.14	0.13
Net Debt / EBITDA	-1.04	-1.09	-0.99	-1.07	-1.09
Total Debt / (EBITDA - Capex)	0.17	0.23	0.19	0.16	0.14
Net Debt / (EBITDA - Capex)	-1.61	-1.66	-1.25	-1.23	-1.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	59.9	-5.51	3.42	3.54	0.9
Gross Profit, 1 Yr. Growth %	66.48	-10.18	2.8	3.52	0.7
EBITDA, 1 Yr. Growth %	125.74	-27.87	2.55	2.61	4.48
EBITA, 1 Yr. Growth %	147.9	-32.24	0.55	3.07	3.06
EBIT, 1 Yr. Growth %	152.19	-32.72	0.51	2.77	3.16
Earnings From Cont. Operations, 1 Yr. Growth %	-56.53	-53.17	23.09	-5.32	-2.61
Net Income, 1 Yr. Growth %	-56.53	-53.17	23.09	-5.32	-2.61
Normalized Net Income, 1 Yr. Growth %	149.01	-36.7	8.14	1.01	7.74
Diluted EPS Before Extra, 1 Yr. Growth %	-56.76	-52.43	26.03	-3.27	0.53
Accounts Receivable, 1 Yr. Growth %	36.41	-4.18	5.09	10.21	10.65
Inventory, 1 Yr. Growth %	65.35	47.14	-12.35	-14.35	-10.99
Net Property, Plant and Equip., 1 Yr. Growth %	47.22	12.26	4.3	-1.73	-10.45
Total Assets, 1 Yr. Growth %	23.03	0.1	2.29	2.15	0.31
Tangible Book Value, 1 Yr. Growth %	16.38	0.12	0.99	5.66	4.76
Common Equity, 1 Yr. Growth %	12.02	-0.59	0.81	6.1	5.12
Cash From Operations, 1 Yr. Growth %	77.07	-51.5	38.16	-6.05	-19.64
Capital Expenditures, 1 Yr. Growth %	158.91	-27.22	-39.12	-34.96	-11.36
Levered Free Cash Flow, 1 Yr. Growth %	18.24	-54.05	127.32	0.42	-21.57
Unlevered Free Cash Flow, 1 Yr. Growth %	18.24	-54.05	127.32	0.42	-21.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.15	22.92	-1.15	3.48	2.21
Gross Profit, 2 Yr. CAGR %	29.74	22.28	-3.96	3.16	2.04
EBITDA, 2 Yr. CAGR %	35.22	27.6	-14.15	2.58	3.34
EBITA, 2 Yr. CAGR %	38.14	29.61	-17.63	1.81	2.84
EBIT, 2 Yr. CAGR %	37.76	30.26	-17.95	1.63	2.73
Earnings From Cont. Operations, 2 Yr. CAGR %	32.05	-54.88	-24.07	7.95	-3.98
Net Income, 2 Yr. CAGR %	32.05	-54.88	-24.07	7.95	-3.98
Normalized Net Income, 2 Yr. CAGR %	37.66	25.54	-17.46	4.52	4.08
Diluted EPS Before Extra, 2 Yr. CAGR %	32.37	-54.64	-22.57	10.41	-1.39
Accounts Receivable, 2 Yr. CAGR %	27.69	14.33	0.35	7.62	10.43
Inventory, 2 Yr. CAGR %	43.34	55.98	13.56	-13.36	-12.69
Net Property, Plant and Equip., 2 Yr. CAGR %	32.25	28.56	8.21	1.24	-6.19
Total Assets, 2 Yr. CAGR %	54.15	10.97	1.19	2.22	1.22
Tangible Book Value, 2 Yr. CAGR %	56.07	7.94	0.55	3.3	5.21
Common Equity, 2 Yr. CAGR %	64.05	5.53	0.11	3.42	5.61
Cash From Operations, 2 Yr. CAGR %	25.26	-7.32	-18.14	13.93	-13.11
Capital Expenditures, 2 Yr. CAGR %	63.68	37.27	-33.44	-37.07	-24.08
Levered Free Cash Flow, 2 Yr. CAGR %	21.35	-26.29	1.87	51.08	-11.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.35	-26.29	1.87	51.08	-11.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	26.2	15.77	16.04	0.39	2.61
Gross Profit, 3 Yr. CAGR %	26.56	14.77	15.37	-1.53	2.29
EBITDA, 3 Yr. CAGR %	27.68	9.66	18.49	-8.89	3.05
EBITA, 3 Yr. CAGR %	28.08	8.95	18.93	-11.24	2.03
EBIT, 3 Yr. CAGR %	27.91	8.49	19.3	-11.55	1.95
Earnings From Cont. Operations, 3 Yr. CAGR %	24.48	-6.53	-36.95	-18.28	4.31
Net Income, 3 Yr. CAGR %	24.48	-6.53	-36.95	-18.28	4.31
Normalized Net Income, 3 Yr. CAGR %	28.38	6.25	19.27	-11.71	5.38
Diluted EPS Before Extra, 3 Yr. CAGR %	25.35	-5.89	-36.24	-16.61	7.02
Accounts Receivable, 3 Yr. CAGR %	26.9	16.03	11.16	3.53	8.62
Inventory, 3 Yr. CAGR %	60.54	44.6	28.71	3.37	-12.58
Net Property, Plant and Equip., 3 Yr. CAGR %	32.15	25.22	19.9	4.79	-2.82
Total Assets, 3 Yr. CAGR %	42.52	33.49	8	1.51	1.58
Tangible Book Value, 3 Yr. CAGR %	38.26	34.6	5.57	2.23	3.79
Common Equity, 3 Yr. CAGR %	42.46	38.82	3.93	2.07	3.98
Cash From Operations, 3 Yr. CAGR %	28.34	-8.7	5.87	-14.29	1.42
Capital Expenditures, 3 Yr. CAGR %	21.56	24.93	4.68	-33.95	-29.46
Levered Free Cash Flow, 3 Yr. CAGR %	32.6	-12.21	7.06	1.38	21.27
Unlevered Free Cash Flow, 3 Yr. CAGR %	32.6	-12.21	7.06	1.38	21.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	29.63	20.44	14.45	10.69	10.3
Gross Profit, 5 Yr. CAGR %	29.2	18.74	13.34	9.96	9.84
EBITDA, 5 Yr. CAGR %	31.48	14.51	8.94	6.7	12.16
EBITA, 5 Yr. CAGR %	31.54	13.34	7.35	5.94	12.18
EBIT, 5 Yr. CAGR %	31.44	13.19	7.1	5.6	12.35
Earnings From Cont. Operations, 5 Yr. CAGR %	32.41	9.34	2.15	-0.99	-25.4
Net Income, 5 Yr. CAGR %	32.41	9.34	2.15	-0.99	-25.4
Normalized Net Income, 5 Yr. CAGR %	32.1	11.15	7.59	5.46	12.92
Diluted EPS Before Extra, 5 Yr. CAGR %	32.98	10.25	3.38	0.32	-24.09
Accounts Receivable, 5 Yr. CAGR %	29.39	21.54	15.53	12.59	10.87
Inventory, 5 Yr. CAGR %	53.37	60.62	39.78	17.81	10.21
Net Property, Plant and Equip., 5 Yr. CAGR %	47.02	31.1	22	15.01	8.69
Total Assets, 5 Yr. CAGR %	33.6	27.23	24.27	19.97	5.24
Tangible Book Value, 5 Yr. CAGR %	27.64	23.8	21.72	21.08	5.43
Common Equity, 5 Yr. CAGR %	29.48	25.55	23.71	23.4	4.6
Cash From Operations, 5 Yr. CAGR %	36.48	5.34	7.21	-0.24	-2.18
Capital Expenditures, 5 Yr. CAGR %	41.55	8.33	-4.46	-5.04	-7.94
Levered Free Cash Flow, 5 Yr. CAGR %	33.4	12.82	19.33	8.94	-0.76
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.4	12.82	19.33	8.94	-0.76